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180A MECHANISMS OF HIV INFECTION AND SUPPRESSION (1022-1023) MONDAY AM
1022
RAPID CD4 T CELL DEPLETION IN HUMAN-PBL-SCID MICE BY 
NON-CYTOPATHIC MACROPHAGE-TROPIC ISOLATES OF HIV.
D. E. Mosier, R. J, Gulizia, P. D. Maclsaac, B. E. Torbett, and J. A. Levy. 
The Scripps Research Institute, La Jolla, CA 92037 and UCSF, San 
Francisco, CA 94143
Distinct isolates of human immunodeficiency virus (HIV) differ in their 
ccll tropism, rate of replication, pathogenicity, and ability to induce 
syncytial formation in vitro. We have compared a panel of molecularly 
cloned HIV-1 or HIV-2 isolates which differ in these biologic properties 
for their ability to deplete CD4 T cells in vivo by using them to infect 
SCID mice transplanted with human peripheral blood leukocytes (hu- 
PBL-SCID mice). The macro phage-tropic strains HIV-1sf162 and HIV- 
2'UCl» which are non-cytopathic in vitro, induced the most rapid and 
extensive CD4 T cell depletion in the hu-PBL-SCID mice, whereas HIV- 
lSF33. which is highly cytopathic forT cells in vitro, caused the slowest 
and least extensive CD4 T cell depletion in vivo. The rate of CD4 T cell 
depletion in hu-PBL-SCID mice was not correlated with viral burden, as 
H IV -Isfb showed higher replication capacity than other strains in vivo 
as well as in vitro, The HIV sequences in the env gene that are associated 
with macrophage-tropism thus correlate with enhanced capacity for CD4 
T cell depletion in the hu-PBL-SCID model, but not for cytopathic effects 
in tissue culture. The rate of CD4 depletion is more dependent on the 
particular viral strain than the extent of viral replication, implying a role 
for pathogenic sequences in the gpl20 envelope protein, [supported by 
NIH grants AI29I82, AI30238 (DEM), and AI29394 (JAL)]
1023
HIV‘SPECIFIC T HELPER CELL ACTIVITY IN NEWBORNS OF HIV- 
INFECTED WOMEN. M. Clerici*. AA. V. SisonJ. A. Berzofskv*. T, Rakusan*.
C. Brandt#. P. I. VenzonV f. L. Sever1* and G. M. Shearer*. *Natl. Cancer Inst. 
Bethesda, MD 20892,A Georgetown Univ. Med. Sch., Washington, D.C. 20007, 
^Children's Natl. Med. Ctr,, Washington, D.C. 20010.
Peripheral blood leukocytes (PBL) from HIV-seropositive pregnant 
women and cord blood leukocytes (CBL) from their offspring were studied for in 
vitro T helper cell (TH) function by interleukin 2 (IL-2) production in response to 
HIV and non-HIV antigens to determine whether HIV-specific TH function of 
mother and/or infant correlated with absence of mother-to-infant transmission of 
HIV. Polymerase chain reaction and viral culture assays were performed to 
determine HIV infection of the infarvts. PBL from 10/23 (43%) mothers tested and 
from 10/23 (43%) newborn CBL samples responded to two or more of five synthetic 
gpl60 envelope (env) peptides. Three of the 23 offspring were shown to be HIV- 
infected. All three of the infected newborns were unresponsive to env, and none of 
the 10 offspring who were responsive to env at birth were found to be infected. No 
correlation was detected between the mothers' wu-specific TH response and 
vertical transmission of HIV, and TH reactivity of mother and newborn were not 
correlated. These results demonstrate that exposure to HIV antigens can occur in 
utero, and that such exposure can result in priming of the fetal T helper cell 
compartment. These results also raise the possibility that HIV-specific TH 
immunity may be protective in utero or in neonates.
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CYTOKINES AS REGULATORS OF MYELOID CELL BIOLOGY (1024-1027)
1024
REGULATION OF INTERFERQN-y PRODUCTION BY IL-12, TNF AND 
IL-10 IN SCID SPLENÛCYU5, C.S. Tripp and E .ft. llnanue. 
Washington Un1v, Sch. of Med., St. Louis, MO 63110 
Listeriosis in SCID mice is an established model of IFN-y 
dependent macrophage activation by NK cells in vitro and in 
vivo. Through a T-cell independent pathway, infection with 
Listeria results in the activation of macrophages with high 
expression of class II-MHC molecules. Macrophages that take 
up Listeria release cytokines that induce NK, cells to pro­
duce IFN-y. In this study we demonstrate that IFN-y 
production from SCID splenocytes is stimulated by IL-12 and 
TNF but inhibited by IL-10. IL-12 production is necessary 
for heat killed Listeria monocytogenes (hk-LM) to stimulate 
IFN-y production since neutralization of IL-12 abolishes 
IFN-y production. ftnti-TNF antibodies also inhibit XFN—f 
production. Thus both IL-12 and TNF are co-stimulators for 
IFN-y production. IL-10 inhibits hk-LM stimulated IFN-y 
production by inhibiting TNF and IL-12 production by SCID 
splenocytes as well as by inhibiting these cells1 ability to 
respond to IL-12 and TNF. Conditioned media from peritoneal 
macrophages stimulated with hk-LM contains IL-12, TNF and 
IL-10 which regulate IFN-y production by SCID spleno­
cytes. This data indicate that macrophages produce TNF, 
IL-12 and IL-10 in response to hk-LM; IL-12 and TNF stimu­
lates IFN-y production by NK cells whereas IL-1Û inhibits 
it at both the level of the macrophage and the NK cell.
1025
TNF-a UPREGULATES IL-10 EXPRESSION IN HUMAN PERIPHERAL 
BLOOD MONOCYTES. Çhinpchai Wnnidworanun and Warren Strober Mucosal 
Immunity Section, Laboratory of Clinical Investigation, NIAID, National Institutes 
of Health, Bethesda, MD 20692. In previous studies it has been shown that LPS 
induces an initial burst of inflammatory monokine production in human monocytes, 
which is followed by substantial IL-IQ production; the IL-10 then down-regulates 
the monokine production as well as IL-10 production itself. In the present studies 
we tested the hypothesis that one of the inflammatory monokines is responsible for 
IL-10 production in human monocytes. Accordingly, we co-cultured purified 
human peripheral blood monocytes with a panel of cytokines including TNF-a, 
IL-la, IL-10* IL-6, GM-CSF, TGF-fi and IFN-a; and then measured EL-10 mRNA 
production using a semi-quantitative RT-PCR technique. "We found that TNF*a had 
a m^jor effect on IL-10 mRNA production, inducing a 20-120-fold increase over 
baseline; in contrast, none of the other cytokines had more than 2-3-fold effect. In 
addition, we established that induction of IL-10 by LPS was in fact due to TNF*a by 
showing thaLLPS-mduced EL-10 production by monocytes decreased when the cells 
were cultured in the presence of and-TNF-a antibody. The induction of IL-10 
mRNA by TNF-a in monocytes is dose-dependent and begins between 8-24 hr 
following die addition of the TNF-a; this suggests that the increased IL-10 mRNA 
level is due to do novo mRNA synthesis rather than mRNA stabilization. Finally, 
using an IL-10 bioassay dependent on the capacity to inhibit IFN-y production (a 
"CSIF” assay), we showed lhat the culture medium obtained from TNF-a-treated 
monocytes contains an increased level of IL-10 protein, i.e., the TNF-a effect occurs 
at both the mRNA and protein level. Taken together, these results suggest that 
TNF-a plays a key role in the induction of IL-10 in human monocytes; as such, it 
may induce a molecule that provides a negative feedback for its own production. In 
addition, these studies suggest that TNF-a, via its cffect on IL-10, may affect 
TH1/TI-12 differentiation in T cells,
1026
IL-10 INHIBITS MACROPHAGE (M<j>) CO-STIMULATORY ACTIVITY 
BY SELECTIVELY INHIBITING THE UPREGULATION OF B7 
EXPRESSION. LJ2mg,_P.JS, Unslev. L-YJHuan^ _R, N,Germain, and
E. M. Shevach. LI/NIAID, NIH, Bethesda, MD 20892 and Bristol-Myers 
Squibb, Seattle, V/A 98121,
We have previously demonstrated that the inhibitory effects of IL-10 on 
Con A induced T cell proliferation or IL-2 production by resting murine T 
cells were only observed when Mt}), but not when activated B cells, 
dendritic cells or L cells, were used as accessory cells (AC). To further 
elucidate the mechanism of action of IL-10 on the inhibition of M<J> 
costimulatory activity, we have used a system in which M<J> develop into 
effective costimulator cells and the effect of IL-10 on this process can be 
examined in the absence of T cells, After fixation, resting M(j) have no co- 
srimulatory activity for soluble anti»CD3 induced T cell proliferation nor do 
they express B7. In contrast, M<j> activated by culture, LPS, or IFNy for 
24h and then fixed, were effective AC, expressed B7, and their co­
stimulatory activity was related to their level of cell surface B7 expression. 
Addition of IL-10 during the process of activation resulted in both a 
marked reduction in costimulatory activity and in the upregulation of B7 
expression, The inhibitory effect of IL-10 on the upregulation of B7 was 
selective since the upregulation of both ICAM-1 and MHC class II antigens 
was not affected. Furthermore, the defective costimulatory ability of both 
resting and IL-10 treated Mtj) could be restored by the addition of fixed L 
cells which expressed high levels of B7 following transfection, but not by 
non-transfected L cells. As B7 plays a key role in the costimulation of IL-2 
and IFNy production, the regulation of B7 expression and M<{> costimulatory 
activity by IL-10 may play an important role in the generation of Th2 cells 
or in the induction of T cell anergy.
1027
IL-13 AFFECTS HUMAN M ONOCYTE MORPHOLOGY, 
PHENOTYPE AND FUNCTION. R. jde_Waai_Malefyt. C. Fipdor 
and J. E. de Vries. DNAX Research Institute, Palo Alto, CA 94304, 
NKI, Amsterdam, The Netherlands.
Recently, we cloned the human cDNA homologue of P600, a 
mRNA which is transcribed by activated mouse Th2 clones. Both 
human and mouse P600 proteins were biologically active on 
human monocytes and B cells. Therefore, we proposed that this 
novel cytokine be designated lnterleukin-13 (IL-13). Human IL-13 
is a non-glycosylated protein of 132 aa with a molecular mass (Mr) 
of 10 kD. IL-13 induced changes in the morphology of human 
monocytes. These cells formed long cellular processes and 
adhered strongly to the substrate when cultured in the presence of 
IL-13. In addition, IL-13 strongly enhanced the expression of class
II MHC antigens on monocytes and Induced expression of CD23 
(FceRII). Furthermore, IL-13 inhibited the LPS-induced production
of monokines including 1L-1, IL-6 and JL-8 . Taken together, these
data indicate that IL-13 has important immunoregulatory activities 
on human monocytes.
